Suppr超能文献

右旋糖酐70——早期临床研究令人鼓舞。

Dextran 70--encouraging early clinical studies.

作者信息

Rosenberg S M

机构信息

Richmond Center for Fertility and Endocrinology, Ltd., Virginia 23229.

出版信息

Prog Clin Biol Res. 1990;358:157-63.

PMID:1699240
Abstract

There appears to be significant data both in animal and human studies to support the contention that 32% high molecular weight dextran-70 is of significant benefit in the minimization of surgical adhesion formation--and reformation after lysis. The data would suggest that it is more valuable in more severe cases, and that it tends to be more efficacious in dependent portions of the pelvis supporting, at least in part, the "hydroflotation" theory of its mechanism of action. Allergic reaction is possible but quite rare, and concern about the possible role of dextran-70 in support of clinical bacterial infection appears to be unsubstantiated by both clinical and experimental data.

摘要

动物和人体研究中似乎都有大量数据支持以下观点

32%的高分子量右旋糖酐70在最大程度减少手术粘连形成以及粘连松解后的再形成方面具有显著益处。数据表明,在更严重的病例中它更具价值,并且在骨盆的下垂部位往往更有效,这至少在一定程度上支持了其作用机制的“水浮选”理论。过敏反应是可能的,但非常罕见,而且关于右旋糖酐70可能支持临床细菌感染的担忧,临床和实验数据似乎都未证实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验